Jennifer Schneider, a director at Vertex Pharmaceuticals Incorporated, filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The document, dated 05/15/2024, indicates that Schneider does not beneficially own any securities in the company. The filing, completed on 05/17/2024, is a routine disclosure for directors and was submitted in accordance with Section 16(a) of the Securities Exchange Act of 1934. This formality is part of the regulatory compliance for individuals in Schneider's position, ensuring transparency in the ownership of securities related to the company.

Jennifer Schneider, a director at Vertex Pharmaceuticals Incorporated, filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per Form 3 requirements. The document, dated 05/15/2024, indicates that Schneider does not beneficially own any securities in the company. The filing, completed on 05/17/2024, is a routine disclosure for directors and was submitted in accordance with Section 16(a) of the Securities Exchange Act of 1934. This formality is part of the regulatory compliance for individuals in Schneider's position, ensuring transparency in the ownership of securities related to the company.